Free preview

Acute Inflammatory Demyelinating Polyneuropathy (AIDP)

Overview and clinical definition are open. Full Step 1 details unlock with a plan.

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Acute Inflammatory Demyelinating Polyneuropathy (AIDP) is a condition that affects the nervous system, specifically the nerves outside the brain and spinal cord. It causes the body's immune system to mistakenly attack the protective covering of the nerves, called the myelin sheath. This damage slows down or blocks nerve signals, leading to weakness, numbness, and sometimes paralysis. Symptoms usually start in the legs and can spread to the arms and upper body. The condition can progress quickly and may affect breathing muscles, making it a medical emergency. Recovery can take weeks to months, and some people may have lasting effects.

Clinical Definition

Acute inflammatory demyelinating polyneuropathy (AIDP) is the demyelinating form of Guillain-Barre syndrome (GBS), especially common in Europe and North America. Immune injury to peripheral nerve and nerve-root myelin impairs saltatory conduction, producing conduction slowing or block and sometimes secondary axonal loss. Typical findings are rapidly progressive bilateral weakness, reduced reflexes and distal paresthesias; weakness often ascends from the legs. Nadir is reached within 4 weeks, usually sooner. Respiratory and autonomic involvement can be life-threatening. AIDP is distinct from the axonal GBS subtypes AMAN and AMSAN.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses